Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$269.12+0.00 (+0.00%)
Delayed quote: Sep 8, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 8, 2026, 4:00 PM EDT
Basis: latest reported fiscal quarter. Source: stored company filings; unavailable inputs remain N/A.
The latest quarterly total equity is $84.97B with a quarterly period change of +4.66%. Total equity, also called shareholders' equity or book value, is assets minus liabilities.
Reported quarterly total equity; no daily interpolation.
| Period | Total Equity | % Change |
|---|---|---|
| Quarter ended Jun 2026 | $84.97B | +4.66% |
| Quarter ended Mar 2026 | $81.19B | (0.44%) |
| Quarter ended Dec 2025 | $81.54B | +2.86% |
| Quarter ended Sep 2025 | $79.28B | +1.02% |
| Quarter ended Jun 2025 | $78.47B | +0.47% |
| Quarter ended Mar 2025 | $78.11B | +9.26% |
| Quarter ended Dec 2024 | $71.49B | +1.90% |
| Quarter ended Sep 2024 | $70.16B | (1.93%) |
| Quarter ended Jun 2024 | $71.54B | +2.17% |
| Quarter ended Mar 2024 | $70.02B | +1.81% |
| Quarter ended Dec 2023 | $68.77B | (3.45%) |
| Quarter ended Oct 2023 | $71.23B | (5.22%) |
| Quarter ended Jul 2023 | $75.15B | +6.04% |
| Quarter ended Apr 2023 | $70.87B | (7.73%) |
| Quarter ended Dec 2022 | $76.80B | +2.96% |
| Quarter ended Oct 2022 | $74.60B | (2.30%) |
| Quarter ended Jul 2022 | $76.36B | +2.21% |
| Quarter ended Apr 2022 | $74.71B | +0.93% |
| Quarter ended Dec 2021 | $74.02B | +5.34% |
| Quarter ended Oct 2021 | $70.27B | +0.99% |
| Quarter ended Jul 2021 | $69.58B | +5.69% |
| Quarter ended Apr 2021 | $65.83B | +4.04% |
| Quarter ended Dec 2020 | $63.28B | (1.85%) |
| Quarter ended Sep 2020 | $64.47B | +2.37% |
| Quarter ended Jun 2020 | $62.98B | +2.75% |
| Quarter ended Mar 2020 | $61.29B | +3.07% |
| Quarter ended Dec 2019 | $59.47B | +2.17% |
| Quarter ended Sep 2019 | $58.21B | (4.24%) |
| Quarter ended Jun 2019 | $60.78B | +3.10% |
| Quarter ended Mar 2019 | $58.95B | (1.33%) |
| Quarter ended Dec 2018 | $59.75B | (7.54%) |
| Quarter ended Sep 2018 | $64.63B | +2.76% |
| Quarter ended Jul 2018 | $62.89B | (0.58%) |
| Quarter ended Apr 2018 | $63.26B | +5.14% |
| Quarter ended Dec 2017 | $60.16B | (18.68%) |
| Quarter ended Oct 2017 | $73.98B | +2.86% |
| Quarter ended Jul 2017 | $71.92B | +2.25% |
| Quarter ended Apr 2017 | $70.34B | (0.11%) |
| Quarter ended Dec 2016 | $70.42B | (3.23%) |
| Quarter ended Oct 2016 | $72.77B | +0.41% |
| Quarter ended Jul 2016 | $72.47B | (0.24%) |
| Quarter ended Apr 2016 | $72.65B | +2.10% |
| Quarter ended Dec 2015 | $71.15B | (0.56%) |
| Quarter ended Sep 2015 | $71.55B | +0.59% |
| Quarter ended Jun 2015 | $71.13B | +4.79% |
| Quarter ended Mar 2015 | $67.88B | (2.69%) |
| Quarter ended Dec 2014 | $69.75B | (8.93%) |
| Quarter ended Sep 2014 | $76.59B | (1.87%) |
| Quarter ended Jun 2014 | $78.05B | +1.91% |
| Quarter ended Mar 2014 | $76.58B | +3.42% |
| Quarter ended Dec 2013 | $74.05B | +6.09% |
| Quarter ended Sep 2013 | $69.80B | +0.20% |
| Quarter ended Jun 2013 | $69.67B | +4.20% |
| Quarter ended Mar 2013 | $66.86B | +3.13% |
| Quarter ended Dec 2012 | $64.83B | +1.67% |
| Quarter ended Sep 2012 | $63.76B | +5.51% |
| Quarter ended Jul 2012 | $60.43B | (1.52%) |
| Quarter ended Apr 2012 | $61.37B | +7.51% |
| Quarter ended Dec 2011 | $57.08B | (7.23%) |
| Quarter ended Oct 2011 | $61.53B | (0.97%) |
| Quarter ended Jul 2011 | $62.13B | +3.79% |
| Quarter ended Apr 2011 | $59.86B | +5.80% |
| Quarter ended Dec 2010 | $56.58B | (1.24%) |
| Quarter ended Oct 2010 | $57.29B | +8.40% |
| Quarter ended Jul 2010 | $52.85B | (0.12%) |
| Quarter ended Apr 2010 | $52.91B | +4.60% |
| Quarter ended Dec 2009 | $50.59B | +0.40% |
| Quarter ended Sep 2009 | $50.38B | +8.95% |
| Quarter ended Jun 2009 | $46.25B | +5.61% |
| Quarter ended Mar 2009 | $43.79B | +3.01% |
| Quarter ended Dec 2008 | $42.51B | (7.05%) |
| Quarter ended Sep 2008 | $45.73B | (1.51%) |
| Quarter ended Jun 2008 | $46.44B | +1.78% |
| Quarter ended Mar 2008 | $45.63B | +5.32% |
| Quarter ended Dec 2007 | $43.32B | (0.58%) |
| Quarter ended Sep 2007 | $43.57B | +1.05% |
| Quarter ended Jul 2007 | $43.12B | +5.36% |
| Quarter ended Apr 2007 | $40.93B | +4.09% |
| Quarter ended Dec 2006 | $39.32B | (3.09%) |
| Quarter ended Oct 2006 | $40.57B | (0.41%) |
| Quarter ended Jul 2006 | $40.74B | (0.93%) |
| Quarter ended Apr 2006 | $41.12B | +6.23% |
| Quarter ended Dec 2005 | $38.71B | +5.06% |
| Quarter ended Oct 2005 | $36.85B | +4.77% |
| Quarter ended Jul 2005 | $35.17B | +4.50% |
| Quarter ended Apr 2005 | $33.65B | +5.79% |
| Quarter ended Dec 2004 | $31.81B | +0.95% |
| Quarter ended Sep 2004 | $31.51B | +4.86% |
| Quarter ended Jun 2004 | $30.05B | +5.47% |
| Quarter ended Mar 2004 | $28.49B | +6.05% |
| Quarter ended Dec 2003 | $26.87B | +4.39% |
| Quarter ended Sep 2003 | $25.74B | +5.32% |
| Quarter ended Jun 2003 | $24.44B | +1.67% |
| Quarter ended Mar 2003 | $24.04B | +5.90% |
| Quarter ended Dec 2002 | $22.70B | +2.77% |
| Quarter ended Sep 2002 | $22.09B | N/A |